Hero image with Pittsburgh background https://pittplusme.org/study/2208

We're sorry. This study is closed and no longer recruiting participants.

STUDY BASICS

Are you a healthy individual between 18-55 years of age who is fully vaccinated (does not include booster vaccine) for SARS-CoV-2? You may be able to participate in a research study to evaluate the safety of a nasal spray that is being studied for the prevention of SARS-CoV2 (the virus that causes COVID-19). Study participation includes 7 visits over 6-8 weeks. Compensation is provided.


IRB: STUDY21100009
- Phase I Clinical Trial of a Q GRFT Nasal Spray

RESEARCH AREAS:
  COVID-19 , Healthy Volunteer

Age Range
AGE:   18-55
Duration
DURATION:  6-8 weeks
VISITS:  7
Location
LOCATION:  UPMC Magee-Womens Hospital - Oakland
Compensation
COMPENSATION:  Up to $450 & parking pass
Location
PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/2208 and click on "I'm Interested" or call 1-866-438-8230.

LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe

MEET THE RESEARCHER


Katherine Bunge

Katherine Bunge, MD, MPH, is an Assistant Professor, Department of Obstetrics, Gynecology & Reproductive Sciences at Magee-Womens Hospital of UPMC. Dr. Bunge's research interests include investigating the safety of vaginal microbicide products, expanding contraceptive options in HIV prevention trials, and developing alternative microbicide formulations. Dr. Bunge earned her medical and masters degrees from the Johns Hopkins School of Medicine, completed her residency at Northwestern Memorial Hospital, and performed her fellowship at Magee-Womens Hospital of UPMC.